Top accelerator startups

14,448 startups · 29 programs

Humane Genomics

Active · A platform to make artificial viruses as cancer therapeutics.

8signal of 100 · rising 2
  • team of 5Team size · YC's directory+4
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from S21

All of S21

About Humane Genomics

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

YC batch
S21 · Summer 2021
Status, per YC
Active
Category
Other
Team size
5
Location
New York City, NY, USA; New York, NY, USA
Checked
13h ago

YC tags: Hard Tech, Synthetic Biology

Humane Genomics in S21: 391 companies, 34% AI

Humane Genomics: questions

Which YC batch was Humane Genomics in?

Humane Genomics was in Y Combinator's Summer 2021 batch (S21).

Is Humane Genomics still active?

Y Combinator lists Humane Genomics as active.

Where is Humane Genomics based?

Humane Genomics lists New York City, NY, USA; New York, NY, USA as its location on YC's directory.